The First steps in research on hereditary cancer have been taken, but there is still a way to go. Our aim for this Congress is very clear: to set up the basis for creating a Portuguese / European consortium of research on hereditary cancer.
Some of the world’s leading specialists on this field will join us, to share their knowledge, their experiences and most of all their vision on how a network to fight hereditary cancer effectively should look like.
This Congress is organized by Evita – Associação de Apoio a Portadores de Alterações nos Genes relacionados com Cancro Hereditário.
Evita aims to raise awareness in society on the risk of Hereditary Cancer. Its goal is to improve the quality of life for patients and to be the active voice towards authorities, medical and scientific communities, the media, similar associations and the general public.
Institute of Molecular Medicine (IMM), University of Lisbon
Portuguese Cancer Research Association, Portugal (ASPIC)
|14:00 – 14:10||Welcome speech by Nuno Miranda (DGS) and Tamara Milagre (Evita)|
|SESSION 1||Moderators: Leonor David (ASPIC) and Nuno Miranda.|
|14:10 – 14:40||Steven Narod
Women’s College Research Institute, Toronto, Canada
Recent advances in the treatment of hereditary breast cancer.
|14:40 – 15:00||Jacek Gronwald
Pomeranian Medical University, Szczecin, Poland
Selected aspects of prophylactic measures in BRCA1/2 mutation carriers.
|15:00 – 15:20||Rita Schmutzler
University Hospital of Cologne, Germany
The German Consortium.
|15:20 – 15:40||20′ questions session.|
|15:40 – 15:50||10′ coffee break.|
|SESSION 2||Moderators: Joana Paredes (Ipatimup) and Berta Sousa (Sta. Maria).|
|15:50– 16:20||Angela George
ICR, Royal Marsden Hospital, London
The Mainstreaming Cancer Genetics (MCG) programme.
|16:20 – 16:35||Manuel Teixeira
Francisco Gentil Portuguese Oncology Institute, Porto, Portugal (IPOPFG)
Inherited predisposition to prostate cancer.
|16:35 – 16:50||Fátima Vaz
Francisco Gentil Portuguese Oncology Institute, Lisbon, Portugal (IPOLFG)
BRAC1/2 mutations and cancer susceptibility in Portugal.
|16:50 – 17:10||20′ questions session.|
|SESSION 3||Moderators: Nuno Miranda, Luis Costa (IMM, ASPIC) and Steven Narod.|
|17:10 – 18:00||Round Table
Networking in Portugal: Patient referral & Scientific collaboration & International cooperation.
|18:00 – 18:10||Closing speech by Nuno Miranda and Tamara Milagre|
Come and listen to the world’s leading specialists on hereditary cancer.
Together we are stronger
Join us for dinner with our speakers, a unique opportunity to meet and talk with the specialists.
The Networking Buffet Dinner will take place after the congress at the Hotel da Estrela, close to the congress’ premises, at a charge of 30€ per person.
Do not miss this opportunity.
As part of a much bigger project, Natasha is making a documentary style video about her personal experience. Natasha will be in Lisbon presenting her work in process.
Watch in only 20 seconds her preparation and recovery from a preventative double mastectomy with reconstruction, after diagnosis of the BRCA2 genetic mutation.
For your convenience you may benefit from special booking conditions at Hotel da Estrela, where the Networking Buffet will take place.
Lisbon is considered one of the most beautiful cities in the world and worth a visit.
Enjoy and meet the city.